Chapter 4 112 REFERENCES 1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA 2020; 324(8): 782-93. 2. Guan W-j, Ni Z-y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine 2020; 382(18): 1708-20. 3. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. (1756-1833 (Electronic)). 4. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020; 395(10223): 497-506. 5. Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet 2021; 397(10270): 220-32. 6. Morin L, Savale L, Pham T, et al. Four-Month Clinical Status of a Cohort of Patients After Hospitalisation for COVID-19. (1538-3598 (Electronic)). 7. Boscolo-Rizzo P, Guida F, Polesel J, et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). International Forum of Allergy & Rhinology 2021; n/a(n/a). 8. Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Network Open 2021; 4(2): e210830-e. 9. BodyPolitic. About Us. Available at: https://www.wearebodypolitic.com/about-body-politic. 10. Calvo-Bonacho E, Catalina-Romero C, Fernández-Labandera C, et al. COVID-19 and Sick Leave: An Analysis of the Ibermutua Cohort of Over 1,651,305 Spanish Workers in the First Trimester of 2020. (2296-2565 (Print)). 11. Chen SI, DO. ; Pierri, N. ; Presbitero, AF. Tracking the Economic Impact of COVID-19 and Mitigation Policies in Europe and the United States. IMF Working Papers 2020; (Working Paper No. 20/125). 12. RIVM. Status validatie SARS-CoV-2 antigeensneltesten In: Infectieziektebestrijding C. 19 July 2021 ed. Bilthoven: RIVM, 2021. 13. GeurtsvanKessel, C.H., Okba, N.M.A., Igloi, Z. et al. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Nat Commun 11, 3436 (2020). https:// doi.org/10.1038/s41467-020-17317-y 14. ISARIC. Clinical Data Collection – The COVID-19 Case Report Forms (CRFs). Available at: https:// isaric.org/research/covid-19-clinical-research-resources/covid-19-crf/. Accessed 18 Feb. 15. National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19 NG188 Vol. 2021: NICE, 2021. 16. World Health Organization (WHO). Clinical management of COVID-19, 2020 27 May 17. Council MR. MRC Dyspnoea scale / MRC Breathlessness scale. Available at: https://mrc.ukri. org/research/facilities-and-resources-for-researchers/mrc-scales/mrc-dyspnoea-scale-mrcbreathlessness-scale/. Accessed March 26. 18. World Health Organization (WHO). Clinical management of COVID-19: WHO Headquarters (HQ), 2020. 19. Stronks K, Kulu-Glasgow I, Agyemang C. The utility of ‘country of birth’ for the classification of ethnic groups in health research: the Dutch experience. Ethnicity & Health 2009; 14(3): 255-69.
RkJQdWJsaXNoZXIy MTk4NDMw